TY  - JOUR

T1  - Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - PharmacoEconomics

UR  - https://eprints.whiterose.ac.uk/128014/

PY  - 2018/08/01

AU  - Pandor A

AU  - Stevenson M

AU  - Stevens J

AU  - James MM-S

AU  - Hamilton J

AU  - Byrne J

AU  - Rudin C

AU  - Rawdin A

AU  - Wong R

ED  - 

DO  - DOI: 10.1007/s40273-018-0627-4

PB  - Springer Science and Business Media LLC

VL  - 36

IS  - 8

SP  - 903

EP  - 915

Y2  - 2024/09/20

ER  -